Explain this page
Arphra AIPlain-English read on Zimmer Biomet Holdings, Inc.’s valuation06-08today
- Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock14h
- Zimmer Biomet: Does Slow And Steady Still Win The Race?21h
- Zimmer Biomet Holdings, Inc. (ZBH) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript8d
- Zimmer Biomet Holdings, Inc. (ZBH) Presents at Bank of America Global Healthcare Conference 2026 Transcript34d
AI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
$287.62
+221.97% vs spot
Recommendation
Strong Buy
18 of 19 methods
Method spread
8bull8bear
±5% threshold
Analyst PT consensus: $97.90 (+9.59%)
Candlestick · 1Y
Open in chart workstation →ZBH
88.26-2.16%H 108.29L 79.12MA50 87.77MA200 93.32Avg vol 2.0M
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.21% | +2.08% | +6.73% | -4.26% | -1.74% | -0.66% | -3.07% | -38.01% | -41.73% | -21.10% | +209.42% |
Insider · 30d
History →Bought
$0
0 txns
Sold
$1.1M
8 txns
Net flow
−$1.1M
Aftermarket
LiveLast trade
$89.41
79 sh
Bid
$86.81
200 sh
Ask
$90.00
200 sh
Spread
$3.190
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q1 Mar 2026 | $2.09B | $238.1M | $1.22 |
| Q4 Dec 2025 | $2.24B | $139.5M | $0.70 |
| Q3 Sep 2025 | $2B | $230.9M | $1.16 |
| Q2 Jun 2025 | $2.08B | $152.8M | $0.77 |
| Q1 Mar 2025 | $1.91B | $182M | $0.91 |
| Q4 Dec 2024 | $2.02B | $239.5M | $1.20 |
Sector & industry today
LiveSectors
- Consumer Defensive+0.72%
- Technology+0.67%
- Real Estate+0.47%
- Energy+0.45%
- Industrials-0.32%
- Financial Services-0.45%
- Utilities-0.49%
- Healthcare-0.92%
- Consumer Cyclical-0.94%
- Basic Materials-1.06%
- Communication Services-1.12%
Top industries (issuer's industry highlighted)
- Medical - Devices+0.34%
- Broadcasting-4.30%
- Coal+3.67%
- Hardware, Equipment & Parts-3.62%
- Real Estate - Development-3.31%
- Trucking-3.16%
- Copper-3.02%
- Apparel - Manufacturers-2.63%
- Medical - Equipment & Services-2.31%
- Oil & Gas Energy+2.28%
- Conglomerates-2.28%
- Auto - Dealerships-2.28%
Analyst view
DB · price_targets + analyst_gradesConsensus target
$97.90
+9.59% upside
Low
$83.00
Median
$93.50
High
$120.00
Recent actions
0 ↑0 ↓8 hold
- May 01, 2026
- Apr 01, 2026
- Mar 01, 2026
- Feb 01, 2026
- Jan 01, 2026
News
DB · news_items- Here's Why Zimmer Biomet (ZBH) is a Strong Value Stockzacks.com·Jun 16, 2026
- Zimmer Biomet: Does Slow And Steady Still Win The Race?seekingalpha.com·Jun 16, 2026
- Zimmer Biomet Holdings, Inc. (ZBH) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcriptseekingalpha.com·Jun 08, 2026
- Zimmer Biomet Holdings, Inc. (ZBH) Presents at Bank of America Global Healthcare Conference 2026 Transcriptseekingalpha.com·May 13, 2026
- Zimmer Biomet Increases Share Repurchase Expectations -- Up to $1 Billion by Year Endprnewswire.com·May 12, 2026
- Zimmer Biomet Increases Share Repurchase Expectations -- Up to $1 Billion by Year Endprnewswire.com·May 12, 2026
- Why Zimmer Biomet (ZBH) is a Top Growth Stock for the Long-Termzacks.com·May 04, 2026
- Here's Why Zimmer Biomet (ZBH) is a Strong Value Stockzacks.com·May 01, 2026
Peers
- UTHRUnited Therapeutics Corporation$570.40$25B
- DXCMDexCom, Inc.$61.35$23.67B
- DGXQuest Diagnostics Incorporated$192.67$21.33B
- WSTWest Pharmaceutical Services, Inc.$300.68$21.24B
- LHLabcorp Holdings Inc.$255.84$21.06B
- STESTERIS plc$214.40$21.04B
- ILMNIllumina, Inc.$135.78$20.63B
- INCYIncyte Corporation$96.91$19.36B
Total assets
$23.09B
Total debt
$7.52B
Cash & equiv
$591.9M
Operating CF
$1.7B
Free cash flow
$1.47B
Buybacks
-$487M
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
Winkler Lori officer: SVP and CHRO | Sell | 2,650 | $250.85K | Mar 12, 2026 |
Yi Sang officer: Group President, Asia Pacific | Sell | 1,000 | $96.49K | Feb 12, 2026 |
Yi Sang officer: Group President, Asia Pacific | Sell | 1,200 | $124.3K | Sep 11, 2025 |
Winkler Lori officer: SVP and CHRO | Sell | 1,500 | $156.23K | Sep 08, 2025 |
Winkler Lori officer: SVP and CHRO | Sell | 1,500 | $153.74K | Aug 18, 2025 |
Yi Sang officer: Group President, Asia Pacific | Sell | 800 | $74.01K | Jun 13, 2025 |
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2025 | $8.23B | $1.36B | $705.2M | $3.55 | +8.57% |
| FY 2024 | $7.68B | $1.29B | $903.8M | $4.43 | +11.77% |
| FY 2023 | $7.39B | $1.28B | $1.02B | $4.88 | +13.85% |
| FY 2022 | $6.94B | $696.3M | $231.4M | $1.10 | +3.33% |
| FY 2021 | $6.83B | $860.3M | $401.6M | $1.91 | +5.88% |